[{'source': 'NIAID/NIH', 'target': 'humans', 'rela': 'have crossed the species barrier into', 'type': 'resolved'}, {'source': 'NIAID/NIH', 'target': 'respiratory illness', 'rela': 'have crossed the species barrier', 'type': 'resolved'}, {'source': 'global viromics projects', 'target': 'thousands of coronavirus sequences', 'rela': 'have discovered', 'type': 'resolved'}, {'source': 'these novel viruses', 'target': 'their ability to infect humans ,', 'rela': 'to be functionally test for', 'type': 'resolved'}, {'source': 'we', 'target': 'an approach to rapidly screen lineage B betacoronaviruses , such as SARS-CoV and the recent 2019-nCoV', 'rela': 'Here developed', 'type': 'resolved'}, {'source': 'cell types', 'target': 'different species', 'rela': 'to be infect from', 'type': 'resolved'}, {'source': 'we', 'target': 'receptor usage', 'rela': 'Here developed an approach to rapidly screen lineage B betacoronaviruses , such as SARS-CoV and the recent 2019-nCoV for', 'type': 'resolved'}, {'source': 'an approach to rapidly screen lineage B betacoronaviruses , such as SARS-CoV and the recent 2019-nCoV', 'target': 'receptor usage', 'rela': 'be Here developed for', 'type': 'resolved'}, {'source': 'host protease processing', 'target': 'several lineage B viruses)[attrib=We show]', 'rela': 'is a significant barrier for', 'type': 'resolved'}, {'source': 'B', 'target': 'an unknown receptor', 'rela': 'viruses to enter human cells through', 'type': 'resolved'}, {'source': 'human cells', 'target': 'an unknown receptor', 'rela': 'to be enter through', 'type': 'resolved'}, {'source': 'B', 'target': 'human cells', 'rela': 'viruses to enter', 'type': 'resolved'}, {'source': 'host protease processing', 'target': 'a significant barrier', 'rela': 'is', 'type': 'resolved'}, {'source': 'host protease processing', 'target': 'several lineage B viruses to enter human cells through an unknown receptor)[attrib=We show]', 'rela': 'allows', 'type': 'resolved'}, {'source': 'human ACE2', 'target': 'the recently emerging 2019-nCoV)[attrib=We confirm]', 'rela': 'is the receptor for', 'type': 'resolved'}, {'source': 'different lineage B viruses', 'target': 'entry)[attrib=We also demonstrate]', 'rela': 'can recombine to gain', 'type': 'resolved'}, {'source': 'human ACE2', 'target': 'the receptor', 'rela': 'is', 'type': 'resolved'}, {'source': 'Severe Acute Respiratory Syndrome Coronavirus', 'target': '2003', 'rela': 'first emerged in', 'type': 'resolved'}, {'source': 'Severe Acute Respiratory Syndrome Coronavirus', 'target': 'humans', 'rela': 'first emerged in', 'type': 'resolved'}, {'source': 'several genetically related viruses', 'target': 'Chinese Horseshoes bats', 'rela': 'Shortly thereafter were identified in', 'type': 'resolved'}, {'source': 'technology lead', 'target': 'a boom of virus discovery', 'rela': 'be sequencing to', 'type': 'resolved'}, {'source': 'next generation', 'target': 'a boom of virus discovery', 'rela': 'sequencing technology lead to', 'type': 'resolved'}, {'source': 'many', 'target': 'known human viruses)[enabler=While most of these viruses have never been found in humans]', 'rela': 'are genetically similar to', 'type': 'resolved'}, {'source': 'most of these viruses', 'target': 'humans', 'rela': 'have never been found in', 'type': 'resolved'}, {'source': 'The ¦Â-CoVs', 'target': 'four lineages', 'rela': 'are further divided into', 'type': 'resolved'}, {'source': 'lineage B', 'target': 'lineage C which includes MERSCoV , has over 500 viral sequences', 'rela': 'published virus sequences whereas', 'type': 'resolved'}, {'source': 'virus sequences', 'target': 'lineage C which includes MERSCoV , has over 500 viral sequences', 'rela': 'be published whereas', 'type': 'resolved'}, {'source': 'lineage B', 'target': 'virus sequences', 'rela': 'published', 'type': 'resolved'}, {'source': 'MERSCoV', 'target': 'over 500 viral sequences', 'rela': 'has', 'type': 'resolved'}, {'source': 'additional novel CoV sequences', 'target': 'Every year', 'rela': 'are discovered in', 'type': 'resolved'}, {'source': 'these novel viruses', 'target': 'the potential', 'rela': 'have', 'type': 'resolved'}, {'source': 'it', 'target': 'unknown', 'rela': 'Therefore is', 'type': 'resolved'}, {'source': 'Viral isolation', 'target': 'successful and reverse genetics recovery of recombinant virus is labor-intensive , and expensive', 'rela': 'is rarely', 'type': 'resolved'}, {'source': 'Viral isolation', 'target': 'successful and reverse genetics recovery of recombinant virus is labor-intensive , and expensive', 'rela': 'is', 'type': 'resolved'}, {'source': 'reverse genetics recovery of recombinant virus', 'target': 'synthesis of a single genome', 'rela': 'be expensive as', 'type': 'resolved'}, {'source': 'they', 'target': 'the scale', 'rela': 'are discovered in', 'type': 'resolved'}, {'source': 'novel CoVs', 'target': 'the scale in which they are discovered', 'rela': 'be studying at', 'type': 'resolved'}, {'source': 'Cell entry', 'target': 'cross-species transmission', 'rela': 'is an essential component of', 'type': 'resolved'}, {'source': 'Cell entry', 'target': 'the ¦Â-CoVs', 'rela': 'is an essential component of cross-species transmission for', 'type': 'resolved'}, {'source': 'Cell entry', 'target': 'an essential component of cross-species transmission', 'rela': 'is', 'type': 'resolved'}, {'source': 'essential', 'target': 'the ¦Â-CoVs', 'rela': 'is component of cross-species transmission for', 'type': 'resolved'}, {'source': 'All CoVs', 'target': 'a surface glycoprotein which binds to the host-cell receptor and mediates viral entry8', 'rela': 'encode', 'type': 'resolved'}, {'source': 'a surface glycoprotein', 'target': 'the host-cell receptor and mediates viral entry8', 'rela': 'binds to', 'type': 'resolved'}, {'source': 'a single region of the spike protein', 'target': 'the receptor binding domain', 'rela': 'called', 'type': 'resolved'}, {'source': 'the receptor binding domain', 'target': '¦Â-CoVs', 'rela': 'be called for', 'type': 'resolved'}, {'source': 'a nearby host protease', 'target': 'the spike which releases the spike fusion peptide', 'rela': 'cleaves', 'type': 'resolved'}, {'source': 'the spike fusion peptide', 'target': 'the spike', 'rela': 'be releases by', 'type': 'resolved'}, {'source': 'the spike RBD', 'target': 'capable of folding independently from the rest of the spike protein and contains all of the structural information', 'rela': 'is', 'type': 'resolved'}, {'source': 'the spike RBD', 'target': 'the structural information', 'rela': 'is capable of', 'type': 'resolved'}, {'source': 'Rp3', 'target': 'the virus to enter cells)[attrib=a previous study Additionally showed]', 'rela': 'allowed', 'type': 'resolved'}, {'source': 'the RBD', 'target': 'the lineage B bat virus', 'rela': 'be replacing of', 'type': 'resolved'}, {'source': 'We', 'target': 'a method to functionally test the RBDs from novel lineage B ¦Â-CoVs in place of the SARS-CoV spike RBD ( figure 1 ', 'rela': 'therefore developed', 'type': 'resolved'}, {'source': 'the RBDs', 'target': 'novel lineage B ¦Â-CoVs', 'rela': 'to be functionally test from', 'type': 'resolved'}, {'source': 'the RBDs', 'target': 'place of the SARS-CoV spike', 'rela': 'to be functionally test in', 'type': 'resolved'}, {'source': 'conventional pseudotyping methods', 'target': 'synthesis of the full ~4kb spike sequence', 'rela': 'rely on', 'type': 'resolved'}, {'source': 'us', 'target': 'the receptor usage of all published , unique RBD sequences', 'rela': 'to test', 'type': 'resolved'}, {'source': 'the 2019-nCoV spike', 'target': 'January 2020', 'rela': 'emerged in', 'type': 'resolved'}, {'source': 'the 2019-nCoV spike', 'target': 'China', 'rela': 'emerged in', 'type': 'resolved'}, {'source': 'the 2019-nCoV spike', 'target': 'our study', 'rela': 'emerged as', 'type': 'resolved'}, {'source': 'several previously-unappreciated viruses', 'target': 'compatibility)[attrib=We show]', 'rela': 'exhibit', 'type': 'resolved'}, {'source': 'lineage B RBDs', 'target': 'distinct clades)[attrib=We show]', 'rela': 'divide into', 'type': 'resolved'}, {'source': 'several previously-unappreciated viruses', 'target': 'distinct clades)[attrib=We show]', 'rela': 'divide into', 'type': 'resolved'}, {'source': 'lineage B RBDs', 'target': 'compatibility)[attrib=We show]', 'rela': 'exhibit', 'type': 'resolved'}, {'source': 'another species barrier encountered by lineage B ¦Â-CoVs during 293T , A549 , BHK , Caco-2 , Huh-7.5 , PK-15 , and Vero cells', 'target': 'DMEM', 'rela': 'were maintained in', 'type': 'resolved'}, {'source': 'host protease processing', 'target': 'another species barrier encountered by lineage B ¦Â-CoVs during 293T , A549 , BHK , Caco-2 , Huh-7.5 , PK-15 , and Vero cells', 'rela': 'is', 'type': 'resolved'}, {'source': 'host protease processing', 'target': 'the RDB-receptor interaction', 'rela': 'is another species barrier beyond', 'type': 'resolved'}, {'source': 'penicillin/streptomycin', 'target': '10 %', 'rela': 'be supplemented with', 'type': 'resolved'}, {'source': 'A549', 'target': '293T', 'rela': 'be encountered during', 'type': 'resolved'}, {'source': 'RhiLu , and RhiNi cells', 'target': 'DMEM/F12', 'rela': 'were maintained in', 'type': 'resolved'}, {'source': 'penicillin/streptomycin', 'target': '12 %', 'rela': 'be supplemented with', 'type': 'resolved'}, {'source': 'AJ-primary cells', 'target': 'a lentiviral vector expressing SV40 T-antigen', 'rela': 'were immortalized with', 'type': 'resolved'}, {'source': 'RaKSM-2.5 primary cells', 'target': 'this study similar', 'rela': 'have were immortalized in', 'type': 'resolved'}, {'source': 'optimized', 'target': "a 5' kozak expression sequence", 'rela': 'be appended with', 'type': 'resolved'}, {'source': 'silent mutations', 'target': 'codons 308', 'rela': 'were introduced around', 'type': 'resolved'}, {'source': 'KpnI and XhoI', 'target': 'sites', 'rela': 'digest', 'type': 'resolved'}, {'source': 'silent mutations', 'target': 'SARS-CoV spike', 'rela': 'were introduced for', 'type': 'resolved'}, {'source': 'silent mutations', 'target': 'codons 290', 'rela': 'were introduced around', 'type': 'resolved'}, {'source': 'silent mutations', 'target': 'As6526 spike', 'rela': 'were introduced for', 'type': 'resolved'}, {'source': 'AflII and HindIII', 'target': 'sites', 'rela': 'digest', 'type': 'resolved'}, {'source': 'silent mutations', 'target': 'codons 295', 'rela': 'were introduced around', 'type': 'resolved'}, {'source': 'silent mutations', 'target': 'BM48-31 spike', 'rela': 'were introduced for', 'type': 'resolved'}, {'source': 'AflII and HindIII', 'target': 'sites', 'rela': 'digest', 'type': 'resolved'}, {'source': 'These engineered spike sequences', 'target': 'pcDNA3.1+', 'rela': 'be cloned into', 'type': 'resolved'}, {'source': 'Spike RBDs', 'target': 'first', 'rela': 'were', 'type': 'resolved'}, {'source': 'SARS-CoV , As6526 or BM48-31 engineered spike plasmids', 'target': 'their corresponding restriction enzymes', 'rela': 'were digested with', 'type': 'resolved'}, {'source': 'RBD inserts', 'target': 'water and Infusion', 'rela': 'were resuspended in', 'type': 'resolved'}, {'source': 'digested spike backbone vectors', 'target': 'gel', 'rela': 'be cloned into', 'type': 'resolved'}, {'source': 'All DNA constructs', 'target': 'Sanger', 'rela': 'were verified by', 'type': 'resolved'}, {'source': 'BHK cells', 'target': 'black 96-well plates', 'rela': 'were seeded in', 'type': 'resolved'}, {'source': 'BHK cells', 'target': '100ng plasmid DNA encoding human ACE2 , DPP4 , APN or empty vector', 'rela': 'transfected with', 'type': 'resolved'}, {'source': '293T cells', 'target': '6-well plates pre-coated', 'rela': 'were seeded onto', 'type': 'resolved'}, {'source': 'transfected cells', 'target': 'VSV¦¤G particles', 'rela': 'Twenty-four hours later were infected with', 'type': 'resolved'}, {'source': 'cells', 'target': '2mL DMEM', 'rela': 'be incubated in', 'type': 'resolved'}, {'source': 'cells', 'target': 'one hour incubating at 37¡ãC', 'rela': 'were washed three times after', 'type': 'resolved'}, {'source': 'cells', 'target': 'three times', 'rela': 'were washed', 'type': 'resolved'}, {'source': 'Target cells', 'target': 'black 96-well plates and inoculated', 'rela': 'were seeded in', 'type': 'resolved'}, {'source': 'Target cells', 'target': 'triplicate', 'rela': 'were seeded in', 'type': 'resolved'}, {'source': 'Target cells', 'target': 'equivalent volumes of pseudotype stocks', 'rela': 'were seeded with', 'type': 'resolved'}, {'source': 'pseudotype stocks', 'target': 'DMEM', 'rela': 'were diluted 1:1 in', 'type': 'resolved'}, {'source': 'pseudotype stocks', 'target': 'FBS', 'rela': 'were diluted 1:1 without', 'type': 'resolved'}, {'source': 'a final concentration of 2500¦Ìg/mL', 'target': '37¡ãC', 'rela': 'to were incubated at', 'type': 'resolved'}, {'source': 'a final concentration of 2500¦Ìg/mL', 'target': '15 minutes', 'rela': 'to were incubated for', 'type': 'resolved'}, {'source': 'pseudotype stocks', 'target': '1:1', 'rela': 'were diluted', 'type': 'resolved'}, {'source': 'pseudotype stocks', 'target': 'trypsin experiments', 'rela': 'were diluted 1:1 for', 'type': 'resolved'}, {'source': '1:1', 'target': '2 %', 'rela': 'supplemented with', 'type': 'resolved'}, {'source': 'Samples', 'target': 'cells', 'rela': 'added to', 'type': 'resolved'}, {'source': 'Inoculated plates', 'target': '1200xG', 'rela': 'were centrifuged at', 'type': 'resolved'}, {'source': 'Bright-Glo luciferase reagent', 'target': 'each well', 'rela': 'Approximately 18-20 hours post-infection was added to', 'type': 'resolved'}, {'source': 'the relative light unit', 'target': 'the plate', 'rela': 'be normalizing to', 'type': 'resolved'}, {'source': 'the relative light unit', 'target': 'average', 'rela': 'be normalizing rlu', 'type': 'resolved'}, {'source': '150mM NaCl', 'target': '1 %SDS', 'rela': 'were lysed in', 'type': 'resolved'}, {'source': '50mM Tris-HCl', 'target': '1 %SDS', 'rela': 'were lysed in', 'type': 'resolved'}, {'source': 'Pseudotyped particles', 'target': 'producer cell lysates that were overlaid a 10 % OptiPrep cushion in PBS ( Sigma ) and centrifuged at 20,000¡Á g for 2 hours at 4', 'rela': 'were concentrated from', 'type': 'resolved'}, {'source': 'Lysates and concentrated particles', 'target': 'FLAG', 'rela': 'were analyzed for', 'type': 'resolved'}, {'source': 'Accession numbers', 'target': 'figure s1b', 'rela': 'can be found in', 'type': 'resolved'}, {'source': '293T , A549 , BHK , Caco-2 , Huh-7.5 , PK-15 , and Vero cells', 'target': 'DMEM', 'rela': 'were maintained in', 'type': 'resolved'}, {'source': 'penicillin/streptomycin', 'target': '10 %', 'rela': 'be supplemented with', 'type': 'resolved'}, {'source': 'all structural information necessary', 'target': 'lineage B ¦Â-CoVs is a single , continuous domain', 'rela': 'be contains by', 'type': 'resolved'}, {'source': 'B ¦Â-CoVs', 'target': 'lineage', 'rela': 'is a single , continuous domain of', 'type': 'resolved'}, {'source': 'We', 'target': 'the codon', 'rela': 'introduced silent mutations in', 'type': 'resolved'}, {'source': 'We', 'target': 'silent mutations', 'rela': 'introduced', 'type': 'resolved'}, {'source': 'silent mutations', 'target': 'the codon', 'rela': 'be introduced in', 'type': 'resolved'}, {'source': 'All lineage B sequences', 'target': '29 unique RBD sequences', 'rela': 'parsed to', 'type': 'resolved'}, {'source': 'All lineage B sequences', 'target': 'online repositories', 'rela': 'were downloaded from', 'type': 'resolved'}, {'source': 'All lineage B sequences', 'target': 'downloaded', 'rela': 'were', 'type': 'resolved'}, {'source': 'All lineage B sequences', 'target': 'all published variations of the lineage B RBD', 'rela': 'parsed representing', 'type': 'resolved'}, {'source': 'these RBD clades', 'target': 'phylogenetic analysis of other viral sequences', 'rela': 'were not apparent in', 'type': 'resolved'}, {'source': 'The panel of 29 RBDs', 'target': '3 clades', 'rela': 'phylogenetically cluster into', 'type': 'resolved'}, {'source': 'these RBD clades', 'target': 'not apparent', 'rela': 'were', 'type': 'resolved'}, {'source': 'these RBD clades', 'target': 'the RNA-dependent RNA polymerase', 'rela': 'were not apparent as', 'type': 'resolved'}, {'source': 'We', 'target': 'our pseudotype platform)[enabler=because a lentiviral pseudotypes have failed to accurately reflect viral entry with novel bat coronavirus spike protein7]', 'rela': 'chose VSV over lentiviruses as', 'type': 'resolved'}, {'source': 'We', 'target': 'VSV)[enabler=because a lentiviral pseudotypes have failed to accurately reflect viral entry with novel bat coronavirus spike protein7]', 'rela': 'chose', 'type': 'resolved'}, {'source': 'a lentiviral pseudotypes', 'target': 'viral entry', 'rela': 'have failed to accurately reflect', 'type': 'resolved'}, {'source': 'VSV', 'target': 'our pseudotype platform)[enabler=because a lentiviral pseudotypes have failed to accurately reflect viral entry with novel bat coronavirus spike protein7]', 'rela': 'be chose as', 'type': 'resolved'}, {'source': 'All constructs', 'target': 'similar levels of expression', 'rela': 'exhibited', 'type': 'resolved'}, {'source': 'All constructs', 'target': 'the chimera', 'rela': 'exhibited similar levels of expression in producer cells and incorporation except', 'type': 'resolved'}, {'source': 'All constructs', 'target': 'VSV pseudotypes', 'rela': 'exhibited similar levels of expression in producer cells and incorporation into', 'type': 'resolved'}, {'source': 'similar levels of expression', 'target': 'VSV pseudotypes', 'rela': 'be exhibited into', 'type': 'resolved'}, {'source': 'similar levels of expression', 'target': 'the chimera', 'rela': 'be exhibited except', 'type': 'resolved'}, {'source': 'SARS-CoV , WIV1 and SHC014', 'target': 'cells transfected with human ACE2 ( figure 1e ', 'rela': 'could enter', 'type': 'resolved'}, {'source': 'We', 'target': 'BHK cells', 'rela': 'then infected', 'type': 'resolved'}, {'source': 'that absence of the host protease', 'target': 'viral entry 21-24', 'rela': 'can block', 'type': 'resolved'}, {'source': 'a wide variety of cell types', 'target': 'different host species', 'rela': 'be infected from', 'type': 'resolved'}, {'source': 'we', 'target': 'our lineage B pseudotype panel', 'rela': 'treated', 'type': 'resolved'}, {'source': '1 infected cells', 'target': 'African green monkey kidney', 'rela': 'be only clade human liver from', 'type': 'resolved'}, {'source': '1 infected cells', 'target': 'African green monkey kidney', 'rela': 'be only clade porcine kidney from', 'type': 'resolved'}, {'source': 'human gastrointestinal tract , human liver , and porcine kidney', 'target': 'the absence of exogenous protease', 'rela': 'be only clade 1 infected cells in', 'type': 'resolved'}, {'source': 'human gastrointestinal tract , human liver , and porcine kidney', 'target': 'African green monkey kidney', 'rela': 'be only clade 1 infected cells from', 'type': 'resolved'}, {'source': 'luciferase signal', 'target': 'all cell lines tested in this study ( supp', 'rela': 'to be produce in', 'type': 'resolved'}, {'source': 'particles', 'target': 'luciferase signal', 'rela': 'to produce', 'type': 'resolved'}, {'source': 'all cell lines', 'target': 'this study', 'rela': 'be tested in', 'type': 'resolved'}, {'source': 'We', 'target': 'human variants of known ¦Â-CoV receptors', 'rela': 'tested', 'type': 'resolved'}, {'source': 'We', 'target': 'their ability to mediate cell entry of clade 2 and 3 spike chimeras', 'rela': 'tested human variants of known ¦Â-CoV receptors for', 'type': 'resolved'}, {'source': 'We', 'target': 'human aminopeptidase N', 'rela': 'also tested', 'type': 'resolved'}, {'source': 'APN)', 'target': 'alphacoronaviruses which have been shown to utilize either human ACE2 or human APN for cell entry ( figure 3a ', 'rela': 'be a receptor for', 'type': 'resolved'}, {'source': 'No entry', 'target': 'clade 2 or 3 spikes', 'rela': 'was observed regardless of receptor protease addition with', 'type': 'resolved'}, {'source': 'no entry', 'target': 'the absence of receptor', 'rela': 'Importantly was observed in', 'type': 'resolved'}, {'source': 'protease-mediated entry', 'target': 'receptor-dependent', 'rela': 'is', 'type': 'resolved'}, {'source': '2019nCoV', 'target': 'the cause of a pneumonia outbreak', 'rela': 'was identified as', 'type': 'resolved'}, {'source': 'our study', 'target': 'ongoing', 'rela': 'was', 'type': 'resolved'}, {'source': '2019nCoV', 'target': 'a pneumonia outbreak', 'rela': 'be the cause of', 'type': 'resolved'}, {'source': 'available', 'target': 'human variants of known coronavirus receptors', 'rela': 'tested the RBD with', 'type': 'resolved'}, {'source': 'available', 'target': '2019nCoV', 'rela': 'tested the RBD from', 'type': 'resolved'}, {'source': 'available', 'target': 'our assay', 'rela': 'tested the RBD in', 'type': 'resolved'}, {'source': 'available', 'target': 'the RBD', 'rela': 'tested', 'type': 'resolved'}, {'source': 'the RBD', 'target': 'human variants of known coronavirus receptors', 'rela': 'be tested with', 'type': 'resolved'}, {'source': 'the sequence', 'target': 'available', 'rela': 'Once was publicly', 'type': 'resolved'}, {'source': 'the RBD', 'target': '2019nCoV', 'rela': 'be tested from', 'type': 'resolved'}, {'source': 'the RBD', 'target': 'our assay', 'rela': 'be tested in', 'type': 'resolved'}, {'source': 'The 2019-nCoV RBD', 'target': 'entering cells expressing human ACE2', 'rela': 'was capable of', 'type': 'resolved'}, {'source': 'The 2019-nCoV RBD', 'target': 'capable of entering cells', 'rela': 'was', 'type': 'resolved'}, {'source': 'Consensus sequences of the three lineage B clades', 'target': 'several key differences', 'rela': 'showed', 'type': 'resolved'}, {'source': '1 RBDs', 'target': 'all 14 residues that have been shown through crystallography to interact with human ACE2 ( figure 4a', 'rela': 'contain', 'type': 'resolved'}, {'source': 'The majority of these residues', 'target': 'clades 2 and 3 , which contain additional deletions in surface exposed loops that cluster at the interface with ACE2 ( figure 4 a , b ', 'rela': 'are absent from', 'type': 'resolved'}, {'source': 'surface', 'target': 'loops', 'rela': 'exposed', 'type': 'resolved'}, {'source': 'a series of clade consensus RBD', 'target': 'the minimum number of mutations', 'rela': 'variants to determine', 'type': 'resolved'}, {'source': 'these loops', 'target': 'clade 2 and 3', 'rela': 'be Restoring in', 'type': 'resolved'}, {'source': 'these loops', 'target': 'the loops', 'rela': 'be Restoring from', 'type': 'resolved'}, {'source': 'all 14 ACE2 contact points', 'target': 'clade 2 or 3', 'rela': 'be Introducing in', 'type': 'resolved'}, {'source': '400-501', 'target': '+ clade', 'rela': 'be residues by', 'type': 'resolved'}, {'source': '1', 'target': '400-501', 'rela': 'residues', 'type': 'resolved'}, {'source': 'the entire RBM', 'target': 'ACE2 entry)[attrib=these results show]', 'rela': 'is needed for', 'type': 'resolved'}, {'source': 'strong entry signal', 'target': 'protease-treatment', 'rela': 'be consistently gave following', 'type': 'resolved'}, {'source': 'strong entry signal', 'target': 'human cells', 'rela': 'be consistently gave in', 'type': 'resolved'}, {'source': 'it', 'target': 'human cells', 'rela': 'consistently gave strong entry signal in', 'type': 'resolved'}, {'source': 'We', 'target': 'the clade 2 spike)[enabler=because it consistently gave strong entry signal in human cells following protease-treatment ( figure 2b ) as well as BM48-31 , the only clade 3 spike in our panel]', 'rela': 'selected', 'type': 'resolved'}, {'source': 'it', 'target': 'protease-treatment', 'rela': 'consistently gave strong entry signal following', 'type': 'resolved'}, {'source': 'it', 'target': 'strong entry signal', 'rela': 'consistently gave', 'type': 'resolved'}, {'source': 'their RBD', 'target': 'the consensus RBD', 'rela': 'be replacing with', 'type': 'resolved'}, {'source': 'we', 'target': 'SARS-CoV spike', 'rela': 'did for', 'type': 'resolved'}, {'source': 'their RBD', 'target': 'clade 1', 'rela': 'be replacing from', 'type': 'resolved'}, {'source': 'All chimeric constructs', 'target': 'the exception', 'rela': 'expressed similarly with', 'type': 'resolved'}, {'source': 'Protease treatment', 'target': 'no effect', 'rela': 'had', 'type': 'resolved'}, {'source': 'SARSlineage B RBD chimeras', 'target': 'the entry phenotype of full-length lineage B spikes)[attrib=these findings show]', 'rela': 'reflect', 'type': 'resolved'}, {'source': 'We', 'target': 'the RBD of full-length clade 2 and 3 spike with the consensus RBD from clade 1 and tested pseudotypes', 'rela': 'replaced', 'type': 'resolved'}, {'source': 'The clade 1 consensus RBD', 'target': 'entry of both As6526 and BM48-31 spike only following protease treatment', 'rela': 'efficiently facilitated', 'type': 'resolved'}, {'source': 'protease treatment', 'target': 'pseudotype entry)[enabler=As seen in our previous experiments]', 'rela': 'did not enhance', 'type': 'resolved'}, {'source': 'we', 'target': 'a scalable , BSL2-compatible method', 'rela': 'developed', 'type': 'resolved'}, {'source': 'we', 'target': 'a reductionist approach', 'rela': 'took', 'type': 'resolved'}, {'source': 'the minimal region of the virus', 'target': 'interacting', 'rela': 'testing essential for', 'type': 'resolved'}, {'source': 'we', 'target': 'synthetic biology and molecular engineering)[enabler=Because most of these viruses have never been isolated]', 'rela': 'resorted to', 'type': 'resolved'}, {'source': 'we', 'target': 'a small fragment)[enabler=Because most of these viruses have never been isolated]', 'rela': 'resorted to reduce the burden of gene synthesis to', 'type': 'resolved'}, {'source': 'the burden of gene synthesis', 'target': 'a small fragment', 'rela': 'to reduce to be', 'type': 'resolved'}, {'source': 'we', 'target': 'the burden of gene synthesis)[enabler=Because most of these viruses have never been isolated]', 'rela': 'resorted to reduce', 'type': 'resolved'}, {'source': 'several spikes', 'target': 'entry', 'rela': 'be testing for', 'type': 'resolved'}, {'source': 'the cost and synthesis production time', 'target': 'reduced', 'rela': 'Thus is dramatically', 'type': 'resolved'}, {'source': 'several spikes', 'target': 'our system', 'rela': 'be testing in', 'type': 'resolved'}, {'source': 'this approach', 'target': 'a wide variety of virus-host proteins', 'rela': 'should be applicable to', 'type': 'resolved'}, {'source': 'this approach', 'target': 'applicable', 'rela': 'should be', 'type': 'resolved'}, {'source': 'this approach', 'target': 'theory', 'rela': 'should be applicable in', 'type': 'resolved'}, {'source': 'Coronavirus entry', 'target': 'a multi-step process involving multiple , distinct domains in spike that mediate virus attachment to the cell surface , receptor engagement , protease processing and membrane fusion8', 'rela': 'is', 'type': 'resolved'}, {'source': 'multiple , distinct domains', 'target': 'spike', 'rela': 'be involving in', 'type': 'resolved'}, {'source': 'a multi-step process', 'target': 'spike', 'rela': 'involving multiple , distinct domains in', 'type': 'resolved'}, {'source': 'recent studies', 'target': 'a species barrier22,25-27)[enabler=While the RBD :receptor interaction is most studied in this process]', 'rela': 'have highlighted the major role host protease processing plays as', 'type': 'resolved'}, {'source': 'recent studies', 'target': 'the major role host protease processing plays)[enabler=While the RBD :receptor interaction is most studied in this process]', 'rela': 'have highlighted', 'type': 'resolved'}, {'source': 'the RBD :receptor interaction', 'target': 'this process', 'rela': 'is studied in', 'type': 'resolved'}, {'source': 'Lineage C coronaviruses', 'target': 'MERS-CoV as well as distantly related viruses', 'rela': 'include', 'type': 'resolved'}, {'source': 'human cells', 'target': 'an unidentified receptor', 'rela': 'can be enter through', 'type': 'resolved'}, {'source': 'HKU5 and PDF-2180 spikes', 'target': 'an unidentified receptor', 'rela': 'can enter human cells through', 'type': 'resolved'}, {'source': 'HKU5 and PDF-2180 spikes', 'target': 'human cells', 'rela': 'can enter', 'type': 'resolved'}, {'source': 'we', 'target': 'protease-enhanced entry of lineage B CoVs', 'rela': 'observed', 'type': 'resolved'}, {'source': 'protease', 'target': 'it30', 'rela': 'to activate', 'type': 'resolved'}, {'source': 'protease', 'target': 'the receptor', 'rela': 'may act as well on', 'type': 'resolved'}, {'source': 'protease', 'target': 'it30', 'rela': 'may act as well to activate', 'type': 'resolved'}, {'source': 'Addition of protease', 'target': 'low-expression of ACE2', 'rela': 'facilitated entry in cells with', 'type': 'resolved'}, {'source': 'Addition of protease', 'target': 'entry', 'rela': 'facilitated', 'type': 'resolved'}, {'source': 'entry', 'target': 'low-expression of ACE2', 'rela': 'be facilitated with', 'type': 'resolved'}, {'source': 'evidence of residual trypsin activity', 'target': 'infection', 'rela': 'be Indeed saw after', 'type': 'resolved'}, {'source': 'we', 'target': 'evidence of residual trypsin activity', 'rela': 'Indeed saw', 'type': 'resolved'}, {'source': 'we', 'target': 'infection', 'rela': 'Indeed saw evidence of residual trypsin activity on the cells after', 'type': 'resolved'}, {'source': 'Menachery et al', 'target': 'their trypsin infections26', 'rela': 'also observed cell rounding during', 'type': 'resolved'}, {'source': 'Menachery et al', 'target': 'cell rounding', 'rela': 'also observed', 'type': 'resolved'}, {'source': 'cell rounding', 'target': 'their trypsin infections26', 'rela': 'be also observed during', 'type': 'resolved'}, {'source': 'trypsin', 'target': 'entry of coronaviruses', 'rela': 'is enhancing', 'type': 'resolved'}, {'source': '1 RBDs', 'target': 'nonhuman primate , human and porcine cell lines', 'rela': 'entered', 'type': 'resolved'}, {'source': 'These findings', 'target': 'strong agreement', 'rela': 'are in', 'type': 'resolved'}, {'source': 'a subset of genetically-similar clade suggesting their barrier', 'target': 'the level of protease processing', 'rela': 'However is at', 'type': 'resolved'}, {'source': 'a subset of genetically-similar clade suggesting their barrier', 'target': 'trypsin', 'rela': 'However is with', 'type': 'resolved'}, {'source': 'The other spike', 'target': 'the cells we tested', 'rela': 'did not enter regardless of protease addition', 'type': 'resolved'}, {'source': 'we', 'target': 'clade 2 or 3 spike', 'rela': 'replaced the RBD in', 'type': 'resolved'}, {'source': 'the protease-dependent entry phenotype', 'target': 'the reverse spike chimeras in which we replaced the RBD in clade 2 or 3 spike with a clade 1 RBD ( figure 5d ) , suggesting that either the protease site between S1/S2 is not compatible with the chimeric spike backbone or the protease is not expressed in these cells ( figure s5 ', 'rela': 'Surprisingly was consistent in', 'type': 'resolved'}, {'source': 'the protease site', 'target': 'the chimeric spike backbone or the protease', 'rela': 'is not compatible with', 'type': 'resolved'}, {'source': 'we', 'target': 'the RBD', 'rela': 'replaced', 'type': 'resolved'}, {'source': 'the protease-dependent entry phenotype', 'target': 'consistent', 'rela': 'Surprisingly was', 'type': 'resolved'}, {'source': 'the protease site', 'target': 'not compatible', 'rela': 'is', 'type': 'resolved'}, {'source': 'the RBD', 'target': 'clade 2 or 3 spike', 'rela': 'be replaced in', 'type': 'resolved'}, {'source': 'the spike protease cleavage site', 'target': 'the protease environment of the receptor-bound RBD', 'rela': 'is adapted to', 'type': 'resolved'}, {'source': 'clade 1 spikes', 'target': 'cells expressing human ACE2', 'rela': 'enter', 'type': 'resolved'}, {'source': 'clade 1 spikes', 'target': 'addition of protease', 'rela': 'enter cells expressing human ACE2 without', 'type': 'resolved'}, {'source': 'None of the spike pseudotypes', 'target': 'Rhinolophus cells which has been observed in previous studies', 'rela': 'efficiently entered', 'type': 'resolved'}, {'source': 'following protease treatment', 'target': 'clade 2 RBDs interact', 'rela': 'suggests that', 'type': 'resolved'}, {'source': 'AJi cells', 'target': 'clade', 'rela': 'Surprisingly were selectively permissive for', 'type': 'resolved'}, {'source': 'AJi cells', 'target': 'permissive', 'rela': 'Surprisingly were selectively', 'type': 'resolved'}, {'source': 'most lineage B ¦Â-CoVs', 'target': 'known coronavirus receptors)[attrib=Our results show]', 'rela': 'do not use', 'type': 'resolved'}, {'source': 'any pseudotype entry', 'target': 'the presence of protease and absence of receptor', 'rela': 'Critically did not observe in', 'type': 'resolved'}, {'source': 'we', 'target': 'the presence of protease and absence of receptor', 'rela': 'Critically did not observe any pseudotype entry in', 'type': 'resolved'}, {'source': 'lineage B cell entry', 'target': 'protease treatment', 'rela': 'is still receptor-dependent following', 'type': 'resolved'}, {'source': 'we', 'target': 'any pseudotype entry', 'rela': 'Critically did not observe', 'type': 'resolved'}, {'source': 'lineage B cell entry', 'target': 'receptor-dependent', 'rela': 'is still', 'type': 'resolved'}, {'source': 'a novel lineage B ¦Â-CoV', 'target': 'the etiological agent)[enabler=While our study was ongoing]', 'rela': 'was identified as', 'type': 'resolved'}, {'source': 'our study', 'target': 'ongoing', 'rela': 'was', 'type': 'resolved'}, {'source': 'residues and motifs', 'target': 'all 3 clades)[enabler=so we tested it for receptor usage and observed entry only with human ACE2 but not other known coronavirus receptors ( figure 3d )]', 'rela': 'found in', 'type': 'resolved'}, {'source': 'we', 'target': 'receptor usage and observed entry', 'rela': 'tested it for', 'type': 'resolved'}, {'source': 'it', 'target': 'receptor usage and observed entry', 'rela': 'be tested for', 'type': 'resolved'}, {'source': 'we', 'target': 'it', 'rela': 'tested', 'type': 'resolved'}, {'source': 'cell entry of 2019-nCoV', 'target': 'the other clade 1 spikes tested', 'rela': 'Interestingly was similar to', 'type': 'resolved'}, {'source': 'cell entry of 2019-nCoV', 'target': 'similar', 'rela': 'Interestingly was', 'type': 'resolved'}, {'source': 'cell entry of 2019-nCoV', 'target': 'the backbone of SARS-CoV spike', 'rela': 'Interestingly was similar within', 'type': 'resolved'}, {'source': '2019-nCoV', 'target': 'capable using human ACE2 as efficiently as SARS-CoV ,', 'rela': 'is', 'type': 'resolved'}, {'source': 'More studies', 'target': 'the full spike sequence', 'rela': 'are needed a viral isolate with', 'type': 'resolved'}, {'source': 'More studies', 'target': 'a viral isolate', 'rela': 'are needed', 'type': 'resolved'}, {'source': 'the co-structure of the SARS-RBD', 'target': 'human ACE2', 'rela': 'bound to', 'type': 'resolved'}, {'source': 'the 14 contact points', 'target': 'insufficient', 'rela': 'was', 'type': 'resolved'}, {'source': 'the noncontact residues in the RBM play a supportive and structural role for these contact points , and indeed , these non-contact residues', 'target': 'the clades', 'rela': 'are different between', 'type': 'resolved'}, {'source': 'clade 2 and 3 RBD containing the clade 1 RBM', 'target': 'human ACE2)[attrib=individual show]', 'rela': 'are compatible with', 'type': 'resolved'}, {'source': 'Coronaviruses', 'target': 'recombination', 'rela': 'frequently undergo', 'type': 'resolved'}, {'source': 'large swaths of genetic material', 'target': '34,35', 'rela': 'be gaining at', 'type': 'resolved'}, {'source': 'Coronaviruses', 'target': 'large swaths of genetic material', 'rela': 'frequently undergo recombination gaining', 'type': 'resolved'}, {'source': 'Coronaviruses', 'target': '34,35', 'rela': 'frequently undergo recombination gaining large swaths of genetic material at', 'type': 'resolved'}, {'source': 'recombination', 'target': 'compatibility', 'rela': 'will impart', 'type': 'resolved'}, {'source': 'it', 'target': 'possible', 'rela': 'is', 'type': 'resolved'}, {'source': 'possible', 'target': 'our data', 'rela': 'be Taken together with', 'type': 'resolved'}, {'source': 'the 2019nCoV RBD', 'target': 'most of the contact points', 'rela': 'However contains', 'type': 'resolved'}, {'source': '2019-nCoV', 'target': 'recombination', 'rela': 'arose from', 'type': 'resolved'}, {'source': 'it', 'target': 'possible', 'rela': 'may be', 'type': 'resolved'}, {'source': 'possible', 'target': 'our receptor assay results', 'rela': 'be Taken together with', 'type': 'resolved'}, {'source': ' clade 2 ) spike chimera', 'target': 'protease treatment', 'rela': 'entered cells following', 'type': 'resolved'}, {'source': ' clade 2 ) spike chimera', 'target': 'cells', 'rela': 'entered', 'type': 'resolved'}, {'source': 'we', 'target': 'the SARS-As6526 RBD', 'rela': 'saw with', 'type': 'resolved'}, {'source': 'cells', 'target': 'protease treatment', 'rela': 'be entered following', 'type': 'resolved'}, {'source': 'the chimeric spikes', 'target': 'the entry phenotypes of full-length spikes)[attrib=These data show]', 'rela': 'generally reproduce', 'type': 'resolved'}, {'source': 'likely', 'target': 'As6526 spike', 'rela': 'be needed in', 'type': 'resolved'}, {'source': 'the full length', 'target': 'cells', 'rela': 'Notably did not enter', 'type': 'resolved'}, {'source': 'The capacity to predict the zoonotic potential of newly detected viruses', 'target': 'a lack of functional data', 'rela': 'has been severely hindered by', 'type': 'resolved'}, {'source': 'we', 'target': 'a rapid and cost-effective platform to functionally test large groups of related viruses for zoonotic potential', 'rela': 'Here have developed', 'type': 'resolved'}, {'source': 'large groups of related viruses', 'target': 'zoonotic potential', 'rela': 'to be functionally test for', 'type': 'resolved'}, {'source': 'lineage B spike proteins', 'target': 'entry', 'rela': 'can recombine to gain', 'type': 'resolved'}, {'source': 'several other lineage B coronaviruses', 'target': 'entry', 'rela': 'can recombine to gain', 'type': 'resolved'}, {'source': 'human cells', 'target': 'an unknown receptor', 'rela': 'be entering through', 'type': 'resolved'}, {'source': 'these findings', 'target': 'the importance of continued surveillance of coronaviruses', 'rela': 'underscore', 'type': 'resolved'}, {'source': 'the Rhinolophus cells', 'target': 'this study', 'rela': 'be used in', 'type': 'resolved'}, {'source': 'We', 'target': 'Dr. Anthony Schountz', 'rela': 'would like to thank', 'type': 'resolved'}, {'source': 'We', 'target': 'Dr. Anthony Schountz', 'rela': 'to thank', 'type': 'resolved'}, {'source': 'We', 'target': 'Wu ,F. , Zhao ,S. , Yu,B. , Chen ,Y.-M. , Wang ,W. , Hu,Y. , Song ,Z.-G. , Tao ,Z.-W. , Tian,J.-H. , Pei,Y.-Y. , Yuan ,M.L. , Zhang ,Y.-L. , Dai ,F.-H. , Liu,Y. , Wang , Q.-M. , Zheng ,J.-J. , Xu,L. , Holmes ,E.C. and Zhang ,Y.-Z , the Wuhan Institute of Virology , Chinese Academy of Medical Sciences & Peking Union Medical College', 'rela': 'would also like to acknowledge', 'type': 'resolved'}, {'source': 'We', 'target': 'Wu ,F. , Zhao ,S. , Yu,B. , Chen ,Y.-M. , Wang ,W. , Hu,Y. , Song ,Z.-G. , Tao ,Z.-W. , Tian,J.-H. , Pei,Y.-Y. , Yuan ,M.L. , Zhang ,Y.-L. , Dai ,F.-H. , Liu,Y. , Wang , Q.-M. , Zheng ,J.-J. , Xu,L. , Holmes ,E.C. and Zhang ,Y.-Z , the Wuhan Institute of Virology , Chinese Academy of Medical Sciences & Peking Union Medical College', 'rela': 'to acknowledge', 'type': 'resolved'}, {'source': 'the genome sequence', 'target': 'the scientific community', 'rela': 'be providing to', 'type': 'resolved'}, {'source': 'This work', 'target': 'the Intramural Research Program of the National Institute of Allergy', 'rela': 'was supported by', 'type': 'resolved'}, {'source': 'The authors', 'target': 'no competing interests', 'rela': 'declare', 'type': 'resolved'}, {'source': '17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 a , Primate cells , b , human cells or c , bat cells', 'target': 'VSV-particles pseudotyped with the lineage B chimeric spike panel', 'rela': 'were infected with', 'type': 'resolved'}, {'source': 'VSV-particles', 'target': 'the lineage B chimeric spike panel', 'rela': 'be pseudotyped with', 'type': 'resolved'}, {'source': 'Pseudotypes', 'target': 'addition', 'rela': 'were either left before', 'type': 'resolved'}, {'source': 'Pseudotypes', 'target': 'trypsin', 'rela': 'were either left with', 'type': 'resolved'}, {'source': 'Luciferase', 'target': 'particles produced without pseudotype', 'rela': 'be normalized to', 'type': 'resolved'}, {'source': 'particles', 'target': 'pseudotype', 'rela': 'be produced without', 'type': 'resolved'}, {'source': 'BHK cells', 'target': 'the coronavirus receptor', 'rela': 'be transfected with', 'type': 'resolved'}, {'source': 'Shown', 'target': '3 replicates', 'rela': 'are data from', 'type': 'resolved'}, {'source': 'Pseudotypes', 'target': 'protease treatment', 'rela': 'were used hDPP4 , hAPN , or empty vector , without', 'type': 'resolved'}, {'source': 'Pseudotypes', 'target': 'cells expressing hACE2', 'rela': 'to infect', 'type': 'resolved'}, {'source': 'Pseudotypes', 'target': 'hDPP4', 'rela': 'were used', 'type': 'resolved'}, {'source': 'd', 'target': 'protease treatment', 'rela': 'were used hDPP4 , hAPN , or empty vector , without', 'type': 'resolved'}, {'source': 'Deletions', 'target': 'clades 2 and 3. b', 'rela': 'are indicated for', 'type': 'resolved'}, {'source': 'loops', 'target': 'gray', 'rela': 'be highlighted in', 'type': 'resolved'}, {'source': 'clades 2 and 3. b', 'target': 'human ACE2 and the SARS-S RBD', 'rela': 'be Structure of', 'type': 'resolved'}, {'source': 'VSV pseudotypes', 'target': 'the indicated RBD', 'rela': 'were generated with', 'type': 'resolved'}, {'source': 'c', 'target': 'the indicated RBD', 'rela': 'were generated with', 'type': 'resolved'}, {'source': 'BHKs', 'target': 'human ACE2 or empty vector', 'rela': 'transfected with', 'type': 'resolved'}, {'source': 'Shown', 'target': '3 replicates', 'rela': 'are data for', 'type': 'resolved'}, {'source': 'Silent mutations flanking the RBD', 'target': 'the clade 1 consensus', 'rela': 'facilitated replacing the native RBD with', 'type': 'resolved'}, {'source': 'Silent mutations flanking the RBD', 'target': 'the native RBD', 'rela': 'facilitated replacing', 'type': 'resolved'}, {'source': 'the native RBD', 'target': 'the clade 1 consensus', 'rela': 'be replacing with', 'type': 'resolved'}, {'source': 'Pseudotypes', 'target': 'untreated or treated with trypsin and subsequently', 'rela': 'were left untreated', 'type': 'resolved'}, {'source': 'c', 'target': 'untreated or treated with trypsin and subsequently', 'rela': 'were left untreated', 'type': 'resolved'}, {'source': 'BHK cells', 'target': 'human ACE2', 'rela': 'be transfected with', 'type': 'resolved'}, {'source': 'Pseudotypes', 'target': 'BHK cells', 'rela': 'to infect', 'type': 'resolved'}]